Cargando…

Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation

Vascular disrupting agents (VDAs) have entered clinical trials for over 15 years. As the leading VDA, combretastatin A4 phosphate (CA4P) has been evaluated in combination with chemotherapy and molecular targeting agents among patients with ovarian cancer, lung cancer and thyroid cancer, but still re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yewei, Wang, Shuncong, Zhao, Xiaohui, Feng, Yuanbo, Bormans, Guy, Swinnen, Johan, Oyen, Raymond, Huang, Gang, Ni, Yicheng, Li, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168934/ https://www.ncbi.nlm.nih.gov/pubmed/32024029 http://dx.doi.org/10.3390/diagnostics10020078

Ejemplares similares

Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRI
por: Liu, Yewei, et al.
Publicado: (2019)

Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4P
por: Liu, Yewei, et al.
Publicado: (2017)

Intra-individual comparison of therapeutic responses to vascular disrupting agent CA4P between rodent primary and secondary liver cancers
por: Liu, Ye-Wei, et al.
Publicado: (2018)

Impact of Blood–Brain Barrier to Delivering a Vascular-Disrupting Agent: Predictive Role of Multiparametric MRI in Rodent Craniofacial Metastasis Models
por: Wang, Shuncong, et al.
Publicado: (2022)

Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology
por: Yin, Ting, et al.
Publicado: (2017)

Pictorial Imaging-Histopathology Correlation in a Rabbit with Hepatic VX2 Tumor Treated by Transarterial Vascular Disrupting Agent Administration
por: He, Jintong, et al.
Publicado: (2020)

A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed
por: Wang, Shuncong, et al.
Publicado: (2019)

AI-based MRI auto-segmentation of brain tumor in rodents, a multicenter study
por: Wang, Shuncong, et al.
Publicado: (2023)

Sequential Administrations of a Vascular-Disrupting Agent, High-Intensity Focused Ultrasound, and a Radioactively labeled Necrosis Avid Compound for Eradicating Solid Malignancies
por: Li, Yue, et al.
Publicado: (2022)

Heterogeneity of Synchronous Lung Metastasis Calls for Risk Stratification and Prognostic Classification: Evidence from a Population-Based Database
por: Wang, Shuncong, et al.
Publicado: (2022)

Enhanced Antitumor Efficacy of a Vascular Disrupting Agent Combined with an Antiangiogenic in a Rat Liver Tumor Model Evaluated by Multiparametric MRI
por: Chen, Feng, et al.
Publicado: (2012)

Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions
por: Liang, Wenjie, et al.
Publicado: (2016)

Lipomatous metaplasia identified in rabbits with reperfused myocardial infarction by 3.0 T magnetic resonance imaging and histopathology
por: Feng, Yuanbo, et al.
Publicado: (2013)

Visualization, Quantification and Characterization of Caerulein-Induced Acute Pancreatitis in Rats by 3.0T Clinical MRI, Biochemistry and Histomorphology
por: Yin, Ting, et al.
Publicado: (2017)

An Imaging and Histological Study on Intrahepatic Microvascular Passage of Contrast Materials in Rat Liver
por: Xia, Qian, et al.
Publicado: (2017)

Pancreatic imaging: Current status of clinical practices and small animal studies
por: Yin, Ting, et al.
Publicado: (2017)

Hypothesis: What is the Best We Can Do with Hydroxychloroquine for COVID-19?
por: Wang, Shuncong, et al.
Publicado: (2020)

Exploring Theranostic Potentials of Radioiodinated Hypericin in Rodent Necrosis Models
por: Li, Junjie, et al.
Publicado: (2012)

Vascular disrupting agents in clinical development
por: Hinnen, P, et al.
Publicado: (2007)

Utilisation of Chick Embryo Chorioallantoic Membrane as a Model Platform for Imaging-Navigated Biomedical Research
por: Chen, Lei, et al.
Publicado: (2021)

Towards Stratifying Ischemic Components by Cardiac MRI and Multifunctional Stainings in a Rabbit Model of Myocardial Infarction
por: Feng, Yuanbo, et al.
Publicado: (2013)

Expression of Vascular Endothelial Growth Factor (VEGF) Associated with Histopathological Changes in Rodent Models of Osteoarthritis
por: Yamairi, Fumiko, et al.
Publicado: (2011)

Vascular disrupting agent induced aggregation of gold nanoparticles for photothermally enhanced tumor vascular disruption
por: Hong, Sheng, et al.
Publicado: (2020)

Everolimus halts hepatic cystogenesis in a rodent model of polycystic-liver-disease
por: Temmerman, Frederik, et al.
Publicado: (2017)

Dynamic 3D morphology of chick embryos and allantois depicted nondestructively by 3.0T clinical magnetic resonance imaging
por: Chen, Lei, et al.
Publicado: (2023)

Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications
por: Li, Junjie, et al.
Publicado: (2013)

Sequential Systemic Administrations of Combretastatin A4 Phosphate and Radioiodinated Hypericin Exert Synergistic Targeted Theranostic Effects with Prolonged Survival on SCID Mice Carrying Bifocal Tumor Xenografts
por: Li, Junjie, et al.
Publicado: (2013)

Vascular Disrupting Agent Drug Classes Differ in Effects on the Cytoskeleton
por: Kim, Sujeong, et al.
Publicado: (2012)

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
por: O'Connor, J P B, et al.
Publicado: (2007)

Vascular Disrupting Agent Arsenic Trioxide Enhances Thermoradiotherapy of Solid Tumors
por: Griffin, Robert J., et al.
Publicado: (2012)

Prognostic significance of (18)FDG PET/CT in colorectal cancer patients with liver metastases: a meta-analysis
por: Xia, Qian, et al.
Publicado: (2015)

High-throughput 3D whole-brain quantitative histopathology in rodents
por: Vandenberghe, Michel E., et al.
Publicado: (2016)

Histopathological Evaluation of Contrast-Induced Acute Kidney Injury Rodent Models
por: Kiss, Norbert, et al.
Publicado: (2016)

Increased P2X7 Receptor Binding Is Associated With Neuroinflammation in Acute but Not Chronic Rodent Models for Parkinson’s Disease
por: Crabbé, Melissa, et al.
Publicado: (2019)

Dynamic Contrast-Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Noninvasive Evaluation of Vascular Disrupting Treatment on Rabbit Liver Tumors
por: Shao, Haibo, et al.
Publicado: (2013)

Comparative histopathology of the development of selected neoplasms of the liver, pancreas, and urinary bladder in rodents.
por: Scarpelli, D G
Publicado: (1988)

Metabolic and histopathological effects of sleeve gastrectomy and gastric plication: an experimental rodent model
por: Gulcicek, Osman Bilgin, et al.
Publicado: (2016)

Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel
por: Martinelli, M, et al.
Publicado: (2007)

Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents
por: Zhang, Huiying, et al.
Publicado: (2011)

Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent
por: Lickliter, J D, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gvshgp6ktpcvqnh6cs8qm37uc0